» Go to news main
Neuroendocrine Tumours: Finding Zebras with Nuclear Medicine
Congratulations to Dr. Steven Burrell on his recently published magazine article in ePatient!
Neuroendocrine Tumours: Finding Zebras with Nuclear Medicine
Dr. Steven Burrell
ePatient: Nuclear Medicine and Molecular Imaging, vol. 5 no. 1, pages 52 - 53.
"NEUROENDOCRINE TUMOURS Neuroendocrine Tumours (NETs) are of much clinical interest these days, due to their rising prevalence, unusual clinical manifestations, and new impactful imaging tests and therapies. Unlike most tumours which are associated with a specific organ (such as lung cancer arising from the lungs), NETs arise from specialized neuroendocrine cells disseminated throughout the body. Neuroendocrine cells are similar to nerve cells (neurons), but they also produce hormones like endocrine cells. The small bowel is the most common site of origin, with the pancreas and lungs also being common. Other sites include the adrenal glands, other parts of the gastrointestinal tract, and less frequently the thyroid, prostate, ovaries, and other organs.
Recent News
- ‘A paradigm shift': A first in Canada, donor‑funded nuclear medicine scanner is helping QEII physicians assess and diagnose diseases with precision that wasn’t previously possible — all while tackling waitlists with greater efficiency
- New interventional radiology suite and hybrid operating room at the Halifax Infirmary
- Nova Scotia gets first‑in‑Canada relocatable MRI
- QEII welcomes the first GE StarGuide SPECT‑CT scanner in Canada.
- The first 68Ga‑PSMA PET scans in Atlantic Canada mark a new era in prostate cancer assessment
- Dr. David Volders awarded the Dr. Charles Lo Prize in Radiology Research
- Radiology Research Day 2024
- Program Administrator Award of Excellence
Comments
comments powered by Disqus